British drugmaker GSK named insider Luke Miels as its CEO designate on Monday to succeed Emma Walmsley, who will step down ...

GSK's CEO Emma Walmsley will step down in December and be replaced by insider Luke Miels, the British drugmaker said on ...

(Reuters) -British drugmaker GSK named insider Luke Miels as its CEO designate on Monday to succeed Emma Walmsley, who will ...

GSK's CEO Emma Walmsley will step down at the end of the year and be replaced by insider Luke Miels, the drugmaker said on ...

GSK CEO Emma Walmsley will step down in January, with Luke Miels taking over amidst looming US tariffs on branded ...

GSK appoints Luke Miels as CEO designate, set to lead the company into a pivotal growth phase starting January 2026.

GSK's CEO Emma Walmsley will step down at the end of the year and be replaced by insider Luke Miels, the drugmaker said on ...

GSK has confirmed that Dame Emma Walmsley will step down as its chief executive office (CEO) at the end of this year, with ...

GSK names Luke Miels as next CEO, succeeding Emma Walmsley at a pivotal time as the drugmaker sets ambitious growth targets ...

GSK plc (NYSE: GSK) appointed Luke Miels as the CEO Designate of GSK. He will assume full responsibility as CEO and join the ...

GSK plc announces that Luke Miels is appointed CEO designate, GSK. He will assume full responsibilities as CEO and join the ...

Emma Walmsley, who in 2017 became the first woman to lead a major pharmaceutical company, will step down from her post as CEO ...